Lesion progression and plaque composition are not altered in older apoE-/- mice lacking tumor necrosis factor-alpha receptor p55

Atherosclerosis. 2004 Oct;176(2):227-32. doi: 10.1016/j.atherosclerosis.2004.05.033.

Abstract

Background: Inflammatory processes are an integral component of the initiation, progression, and destabilization of atherosclerotic lesions. Tumor necrosis factor-alpha (TNF-alpha) is considered a primary mediator of inflammatory processes.

Methods and results: The role of TNF-alpha in plaque progression and plaque destabilization was investigated in the innominate arteries of older TNF-alpha receptor p55 deficient mice that were generated on a hyperlipidemic apolipoprotein E deficient background (p55-/- apoE-/-). There were no significant differences in levels of circulating cytokines, plaque progression, plaque composition or features of plaque destabilization in p55-/- apoE-/- compared to wild type (p55+/+ apoE-/-) mice.

Conclusions: Progression and destabilization of advanced atherosclerotic lesions does not seem to be mediated via the TNF-alpha receptor p55.

MeSH terms

  • Aging / physiology
  • Animals
  • Apolipoproteins E / genetics*
  • Apolipoproteins E / pharmacology
  • Arteriosclerosis / genetics
  • Arteriosclerosis / physiopathology*
  • Disease Progression
  • Hyperlipidemias / genetics
  • Hyperlipidemias / physiopathology
  • Mice
  • Receptors, Tumor Necrosis Factor / genetics*
  • Receptors, Tumor Necrosis Factor / physiology
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Apolipoproteins E
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha